Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos

Inward Investment
Return to: PBR Home | Inward Investment

Inward Investment

PPF Group acquires minority stake in Cytune Pharma By PBR Staff Writer
PPF Group, in cooperation with SOTIO has completed acquisition of minority stake in French biotechnology firm Cytune Pharma.
Inward Investment > News
Merck in talks to acquire Cubist Pharmaceuticals for nearly $8bn By PBR Staff Writer
New Jersey-based drug giant Merck & Co is, reportedly, in talks over a potential acquisition of antibiotics maker Cubist Pharmaceuticals for more than $8bn.
Inward Investment > News Endo International to buy Auxilium Pharmaceuticals for $2.6bn By PBR Staff Writer
Ireland-based Endo International has signed an agreement to acquire Auxilium Pharmaceuticals, in a deal that is worth nearly $2.6bn.
Inward Investment > News
See more Inward Investment news

Latest Inward Investment News and Insight

View all Inward Investment news or find news targeted to your interests
Eppendorf and Florida State University Collaboration Demonstrates Large-Scale Stem Cell Expansion
A collaboration between Eppendorf and Florida State University has successfully shown the feasibility of large-scale expansion of human mesenchymal stem cells (MSC) using the company's proprietary Fibra-Cel® packed-bed technology.
Inward Investment > Press Releases
High Cell Density Fermentation of Escherichia coli Using the New Brunswick™ BioFlo® 115
| By Eppendorf
This application note presents a successful example of a high density fermentation of Escherichia coli (E. coli) using the New Brunswick BioFlo 115 benchtop, autoclavable fermentor from Eppendorf. The highest optical density (OD600) achieved in this study was 140 at 11 hours (h) without optimized fermentation medium and conditions.
Inward Investment > White Papers
PPF Group acquires minority stake in Cytune Pharma
By PBR Staff Writer
PPF Group, in cooperation with SOTIO has completed acquisition of minority stake in French biotechnology firm Cytune Pharma.
Inward Investment > News
Eppendorf Announces New BioFlo320 Bench Scale Bioprocess Control Station®
The BioFlo 320 is truly a step into the future for Eppendorf as a bioprocess equipment manufacturer. New features including autoclavable and single-use vessel flexibility, intelligent sensors, and IP network communication for multi-unit control set it apart as the new premium choice in the bench scale bioprocess market.
Inward Investment > Press Releases
Evaluation of the BioFlo® 320 Process Capabilities
| By Eppendorf
This poster characterizes the capabilities of the BioFlo320 in terms of key process parameters including oxygen transfer rate (OTR), volumetric mass transfer coecient (kLa), tip speed, mixing time, and water consumption. These data enable quantitative analyses of bioprocess engineering parameters, thus allowing potential users to gain insight into the system’s cell culture and fermentation capabilities.
Inward Investment > White Papers
The Smarter Solution
| By Eppendorf
BioFlo® 320 bioprocess control station.
Inward Investment > White Papers
BioFlo 320
The BioFlo 320 seamlessly blends beauty and utility in one all-inclusive package. A new industrial design, flexibility between interchangeable autoclavable and single-use vessels, intelligent sensors, Ethernet connectivity, and a new software package are only a few of the features that set it apart from the competition.
Inward Investment > Products
Eppendorf BioBLU® Single-Use Vessels
Eppendorf BioBLU Single-Use Vessels combine all the advantages of single-use technology with the trusted performance and scalability of a stirred-tank design. Single-use vessels eliminate autoclaving, improve turn-around time, simplify validation, and reduce overall costs. The BioBLU portfolio has grown to accommodate users from early research and development through manufacturing, across a wide variety of processes, including shear sensitive cell cultures, robust microbial applications, and adherent cell line development.
Inward Investment > Products
Eppendorf DASbox® Mini Bioreactor System
The DASbox is a unique mini bioreactor system suitable for microbial and cell culture as well as stem cell applications. It is designed as a 4-fold system combinable to operate up to twenty-four parallel operating bioreactors. With working volumes of 60 – 250 mL the DASbox is the optimal tool for advanced process development and Design of Experiments (DoE) applications. All critical process parameters can be precisely controlled. Liquid-free temperature control and exhaust condensation satisfy users with easy handling.
Inward Investment > Products
Eppendorf DASGIP® Parallel Bioreactor System
DASGIP Parallel Bioreactor Systems for R&D and process development in both cell culture and microbiology allow for advanced bioprocess control and automation. Parallel processing, precise control of all relevant parameters, user-defined profiles and innumerable automation features result in accelerated and highly efficient process development. Our DASware software solutions support DoE, process historians and comprehensive data management. Configurable solutions address the unique requirements of microbial, phototrophic, mammalian and human cells, stem cell applications, as well as biofuel and biopolymer processes.
Inward Investment > Products
View all Inward Investment news or find news targeted to your interests